• Fatty liver disease ranges from:
    • Benign condition of metabolic dysfunction-associated steatotic liver disease (MASLD) - previously called NAFLD
      • Hepatic steatosis is present without evidence of inflammation
    • Metabolic dysfunction-associated steatohepatitis (MASH) - previously called (NASH)
      • Hepatic steatosis is associated with lobular inflammation and apoptosis that can lead to fibrosis and cirrhosis